Table 2.
Subgroup analysis
Subgoup | Sex (♀/♂) |
Age | BMI | Baseline AHI | Treated AHI | % reduction |
---|---|---|---|---|---|---|
All | 5/7 | 48.1 ± 10.7 | 30.6 ± 6.8 | 30.1 ± 11.3 | 29 ± 24.2 | 16.3 ± 50.9 |
Female | 5/0 | 51.2 ± 8.6 | 32.9 ± 10.5 | 24.5 ± 7.2 | 17 ± 21 | 39.9 ± 59.9 |
Female, BMI < 35 | 4/0 | 50.5 ± 9.8 | 28.7 ± 5.2 | 22.5 ± 6.5 | 7.6 ± 2.8 |
66.6 ± 3.8 (a) |
Male | 0/7 | 47.9 ± 12.1 | 29.4 ± 2.4 | 34.1 ± 12.4 | 37.7 ± 23.9 | -0.5 ± 39.5 |
BMI < 32 | 2/6 | 47.1 ± 12.9 | 27.7 ± 2.8 | 30.5 ± 11.8 | 27.2 ± 22.6 | 21.2 ± 42.5 |
BMI < 35 | 4/7 | 47.5 ± 8 | 29.1 ± 2.6 | 29.9 ± 10.3 | 26.7 ± 20 | 23.9 ± 39.5 |
ashows a significant decrease in AHI using a non-parametric Wilcoxon test